000504 南华生物
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资5,4160.00%5,4165,4845,9756,299
投资性房地产0--0000
固定资产14,108-1.22%14,28220,36216,50911,595
在建工程0--001,2860
无形资产427-3.17%4413612181,544
商誉1,9830.00%1,9838,4418,44111,231
其他非流动资产91,539-3.04%94,410102,481110,19345,771
113,472-2.63%116,531137,130142,62276,439

流动资产
货币资金212,628-56.94%493,811218,148153,00567,038
应收账款124,1670.77%123,224158,759196,119188,791
存货14,21333.33%10,6604,50110,64014,931
其他流动资产146,822440.68%27,15534,828156,860208,941
497,830-23.98%654,851416,236516,623479,701

流动负债
短期借款28,111-0.02%28,11763,08332,91013,015
应付票据0--0000
应付帐款79,461-3.35%82,21382,03289,56260,692
其他流动负债186,805-45.39%342,068310,037406,531344,554
294,377-34.93%452,397455,152529,002418,261
流动资产净值203,4530.49%202,454(38,916)(12,379)61,439
资产总额减流动负债316,925-0.65%318,98698,215130,243137,879

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债15,0985.49%14,31218,02919,9243,397
15,0985.49%14,31218,02919,9243,397

总权益
    实收股本330,0230.00%330,023311,574311,574311,574
    储备项目(75,853)3.79%(73,082)(297,565)(294,934)(285,005)
股东权益254,171-1.08%256,94114,00916,64026,569
非控股权益47,657-0.16%47,73366,17793,679107,913